questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Thérapie comportementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles du comportement
Évaluation psychologique
Tests psychologiques
Évaluation comportementale
Psychologie clinique
Psychiatrie
Critères diagnostiques
Comportement anormal
Troubles mentaux
Thérapie comportementale
Symptômes
5
Variabilité des symptômes
Troubles du comportement
Symptômes physiques
Troubles psychosomatiques
Évolution des symptômes
Impact sur la vie quotidienne
Amélioration des symptômes
Gestion des émotions
Prévention
5
Prévention des troubles
Éducation émotionnelle
Programmes scolaires
Sensibilisation
Rôle parental
Gestion du stress
Prévention chez les adultes
Gestion du stress
Groupes de soutien
Stratégies de prévention
Traitements
5
Conditionnement opérant
Restructuration cognitive
Durée du traitement
Thérapie
Thérapie combinée
Médicaments psychotropes
Objectifs thérapeutiques
Compétences d'adaptation
Thérapie pour enfants
Troubles de l'enfance
Complications
5
Complications psychologiques
Impact social
Effets secondaires
Réactions émotionnelles
Rechute
Compétences acquises
Santé physique
Troubles psychosomatiques
Soutien social
Pratique des compétences
Facteurs de risque
5
Facteurs de risque
Stress
Environnement familial
Conflits familiaux
Antécédents médicaux
Hérédité
Soutien social
Gestion des troubles
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale : Questions médicales les plus fréquentes",
"headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de maitrise de la colère",
"alternateName": "Anger Management Therapy",
"url": "https://questionsmedicales.fr/mesh/D000067449",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de maitrise de la colère",
"code": {
"@type": "MedicalCode",
"code": "D000067449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse comportementale appliquée",
"alternateName": "Applied Behavior Analysis",
"url": "https://questionsmedicales.fr/mesh/D000072357",
"about": {
"@type": "MedicalCondition",
"name": "Analyse comportementale appliquée",
"code": {
"@type": "MedicalCode",
"code": "D000072357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"url": "https://questionsmedicales.fr/mesh/D001348",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie cognitive",
"alternateName": "Cognitive Behavioral Therapy",
"url": "https://questionsmedicales.fr/mesh/D015928",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie cognitive",
"code": {
"@type": "MedicalCode",
"code": "D015928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie d'acceptation et d'engagement",
"alternateName": "Acceptance and Commitment Therapy",
"url": "https://questionsmedicales.fr/mesh/D064869",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie d'acceptation et d'engagement",
"code": {
"@type": "MedicalCode",
"code": "D064869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Restructuration cognitive",
"alternateName": "Cognitive Restructuring",
"url": "https://questionsmedicales.fr/mesh/D000088686",
"about": {
"@type": "MedicalCondition",
"name": "Restructuration cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000088686",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pleine conscience",
"alternateName": "Mindfulness",
"url": "https://questionsmedicales.fr/mesh/D064866",
"about": {
"@type": "MedicalCondition",
"name": "Pleine conscience",
"code": {
"@type": "MedicalCode",
"code": "D064866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Remédiation cognitive",
"alternateName": "Cognitive Remediation",
"url": "https://questionsmedicales.fr/mesh/D000072466",
"about": {
"@type": "MedicalCondition",
"name": "Remédiation cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000072466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale dialectique",
"alternateName": "Dialectical Behavior Therapy",
"url": "https://questionsmedicales.fr/mesh/D000077252",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale dialectique",
"code": {
"@type": "MedicalCode",
"code": "D000077252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par la relaxation",
"alternateName": "Relaxation Therapy",
"url": "https://questionsmedicales.fr/mesh/D012064",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par la relaxation",
"code": {
"@type": "MedicalCode",
"code": "D012064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méditation",
"alternateName": "Meditation",
"url": "https://questionsmedicales.fr/mesh/D019122",
"about": {
"@type": "MedicalCondition",
"name": "Méditation",
"code": {
"@type": "MedicalCode",
"code": "D019122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chronothérapie sur les phases de sommeil",
"alternateName": "Sleep Phase Chronotherapy",
"url": "https://questionsmedicales.fr/mesh/D055865",
"about": {
"@type": "MedicalCondition",
"name": "Chronothérapie sur les phases de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D055865",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"alternateName": "Behavior Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel F Gros",
"url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros",
"affiliation": {
"@type": "Organization",
"name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA."
}
},
{
"@type": "Person",
"name": "Tanja van der Zweerde",
"url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl."
}
},
{
"@type": "Person",
"name": "Jaap Lancee",
"url": "https://questionsmedicales.fr/author/Jaap%20Lancee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Annemieke van Straten",
"url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands."
}
},
{
"@type": "Person",
"name": "Shireen L Rizvi",
"url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi",
"affiliation": {
"@type": "Organization",
"name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2340-1790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of myopia-associated genes in a Han Chinese population with high myopia.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37165999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2023.2191709"
}
},
{
"@type": "ScholarlyArticle",
"name": "Extreme myopia is more susceptible to SOX2 gene than high myopia.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36921835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exer.2023.109435"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of myopia and uncorrected myopia among 721 032 schoolchildren in a city-wide vision screening in southern China: the Shantou Myopia Study.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/36198476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2021-320940"
}
},
{
"@type": "ScholarlyArticle",
"name": "EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36708714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17434440.2023.2174429"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie comportementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie comportementale",
"description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie comportementale",
"description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie comportementale",
"description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie comportementale",
"description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie comportementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie comportementale",
"description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Myopia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie comportementale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic pour cette thérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie comportementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver sans traitement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'amélioration avec la thérapie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les parents dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants."
}
},
{
"@type": "Question",
"name": "La prévention est-elle possible à l'âge adulte ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées en thérapie comportementale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs principaux de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques de rechute existent après la thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques peuvent-elles affecter la santé physique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications après la thérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles comportementaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement familial influence-t-il les comportements ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA.
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Publications dans "Thérapie comportementale" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl.
Publications dans "Thérapie comportementale" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands.
Publications dans "Thérapie comportementale" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Bakırköy Mental Health and Neurological Diseases Education and Research Hospital, Department of Psychiatry, İstanbul, Turkey.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
University of Health Science, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Psychiatry, Ankara, Turkey.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Social Sciences University of Ankara, Department of Psychology, Ankara, Turkey.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Department of Epidemiology, Erasmus MC University Medical Center, Dr. Molewaterplein 40, Rotterdam 3015 GD, the Netherlands.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Kentucky, Lexington, KY, USA. Electronic address: southward@uky.edu.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Kentucky, Lexington, KY, USA.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Baylor College of Medicine, One Baylor Plaza, MS:350, Houston, TX 77030, USA.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Baylor College of Medicine, One Baylor Plaza, MS:350, Houston, TX 77030, USA.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
One Baylor Plaza, MS:350, 1977 Butler Boulevard, Houston, TX 77030, USA.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
UNSW at the Black Dog Institute, Hospital Road, Randwick, New South Wales 2031, Australia; School of Psychology, UNSW Sydney; Black Dog Institute, Hospital Road, Randwick, New South Wales 2031, Australia. Electronic address: j.newby@unsw.edu.au.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Amarum, Expertise Centre for Eating Disorders, GGNet Network for Mental Health Care, Gelderland, Zutphen.
Radboud University, Behavioural Science Institute, Nijmegen, Gelderland.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Amarum, Expertise Centre for Eating Disorders, GGNet Network for Mental Health Care, Gelderland, Zutphen.
Radboud University, Behavioural Science Institute, Nijmegen, Gelderland.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Sanford Center for Biobehavioral Research, Fargo, North Dakota, USA.
School of Medicine and Health Sciences, University of North Dakota, Fargo, North Dakota, USA.
Publications dans "Thérapie comportementale" :
2 publications dans cette catégorie
Affiliations :
Radboud University, Behavioural Science Institute, Nijmegen, Gelderland.
Publications dans "Thérapie comportementale" :
Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and...
High myopia is a leading cause of blindness worldwide. However, the exact etiology and mechanism of high myopia remain unclear. Previous genome-wide association study has demonstrated that nine single...
Seven SNPs were genotyped by the MassARRAY iPLEX Gold method in a Han Chinese cohort with the majority from Henan region (central China), which included 361 patients with high myopia and 749 healthy c...
In terms of genotyped SNPs, the allele frequency of rs698047 locus of the HIVEP3 gene were statistically different between myopia and control groups initially, but the difference disappeared after Bon...
There was no demonstrated association between the occurrence of high myopia in the Chinese Han population and polymorphisms in the following loci: HIVEP3 (rs698047), NFASC/CNTN2 (rs2246661), ZC3H11B (...
To explore the association between two single-nucleotide polymorphisms (SNPs) in the SOX2 gene and high and extreme myopia in the Han Chinese population....
A genetic association study using a case-control method was performed with 139 high myopia, 318 extreme myopia, and 918 healthy participants from the Chinese Han population. Two SNPs (rs4459940 and rs...
The mean ages of the extreme myopia and control subjects were 47.44 ± 15.59 and 44.15 ± 14.08 years, respectively. The rs4575941 SNP of the SOX2 gene and the GG and AG genotypes showed no significant ...
The SOX2 rs4575941 polymorphism, in Chinese Han population, contributes to the susceptibility of extreme myopia. SOX2 may thus be implicated in extreme myopia rather than in high myopia....
To explore the prevalence and risk factors for myopia and uncorrected myopia in schoolchildren in southern China....
The government-led Shantou Myopia Study was conducted from September 2020 to June 2021. Non-cycloplegic refraction was performed. Uncorrected visual acuity (UCVA) was measured along with presenting vi...
This study enrolled 724 828 schoolchildren (77.8% of all schoolchildren in Shantou) from 901 schools. Data from 721 032 schoolchildren (99.5%) were analysed (mean age 11.53±3.13 years, 6-20 years, 373...
The overall prevalence of myopia among schoolchildren in Shantou was 51.8%, higher than the national average in China. The proportion of uncorrected myopia is high, especially in primary schools. Our ...
Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most p...
During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the i...
Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future rese...
Initial studies have suggested that multiple segment (MS) spectacle lenses can reduce the progression rate of childhood myopia and axial eye growth. This paper aimed to compare the effectiveness of tw...
Published data from the only two clinical trials in which changes in mean spherical equivalent refraction (SER) and axial length (AL) for matched groups of myopic children wearing either MS or single-...
Absolute changes in SER and AL differed over time during the two trials. However, if the results were expressed in terms of efficacy over successive 6-month periods, then the two MS lenses produced br...
Myopia control may be due to either the additional myopic defocus induced by the MS lenses (i.e., asymmetry of the through-focus image changes about the distance focus) or to the general reduction in ...
Multiple segment spectacle lenses offer a valuable new approach to the control of myopia progression in children. Further work is required to clarify their mechanism of action and to optimise their de...
This study is a retrospective analysis to compare ocular biometry measurements of axial length in children with myopia using Myopia Master (OCULUS, Wetzlar, Germany) and Lenstar LS900 (HAAG-STREIT AG,...
Axial length measurements obtained with both instruments within a 3-week period were collected retrospectively. Measurements were visualized with a Bland-Altman plot. For statistical evaluation, a pai...
Sixty-one eyes from 31 myopic patients (59% male, 41% female) with a mean age of 11.34 ± 3.25 years (range: 6 - 18 years) were identified. Mean axial length was 24.7 mm (SD 1.29) with the Myopia Maste...
The axial length measured by Myopia Master and Lenstar LS900 did not differ significantly. Thus, previous values obtained with the Lenstar LS900 can be applied to assess myopia progression....
The META-Analysis of Pathologic Myopia Study group proposed a new classification system for myopic maculopathy (MM) with pathologic myopia (PM) defined as MM equal to/more serious than diffuse atrophy...
This study examined the optical impact of a DF contact lens during near viewing in a sample of habitual DF lens wearing children....
Seventeen myopic children aged 14 to 18 years who had completed 3 or 6 years of treatment with a DF contact lens (MiSight 1 Day; CooperVision, Inc., San Ramon, CA) were recruited and fit bilaterally w...
During near viewing, children wearing single-vision lenses accommodated on average to achieve approximate focus in the pupil center but, because of combined accommodative lag and negative spherical ab...
The DF contact lens did not alter the accommodative behavior of children. The treatment optics introduced myopic defocus and decreased the amount of hyperopically defocused light in the retinal image....
The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approa...